233 related articles for article (PubMed ID: 15281897)
21. [Antipsychotic drugs. Risk factors for diabetes].
Stip E; Tranulis C; Légaré N; Poulin MJ
Presse Med; 2003 Oct; 32(34):1612-7. PubMed ID: 14576587
[TBL] [Abstract][Full Text] [Related]
22. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.
Cohen D
Pharmacopsychiatry; 2004 Jan; 37(1):1-11. PubMed ID: 14750042
[TBL] [Abstract][Full Text] [Related]
23. Dyslipidemia and atypical antipsychotic drugs.
Casey DE
J Clin Psychiatry; 2004; 65 Suppl 18():27-35. PubMed ID: 15600382
[TBL] [Abstract][Full Text] [Related]
24. Safety of antipsychotic drugs: focus on therapeutic and adverse effects.
Werner FM; Coveñas R
Expert Opin Drug Saf; 2014 Aug; 13(8):1031-42. PubMed ID: 24975932
[TBL] [Abstract][Full Text] [Related]
25. Atypical antipsychotics and diabetes mellitus.
Lichiardopol R
Rom J Intern Med; 2004; 42(2):301-12. PubMed ID: 15529621
[TBL] [Abstract][Full Text] [Related]
26. Clinical issues associated with maintenance treatment of patients with schizophrenia.
Guthrie SK
Am J Health Syst Pharm; 2002 Sep; 59(17 Suppl 5):S19-24. PubMed ID: 12227083
[TBL] [Abstract][Full Text] [Related]
27. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
Rzewuska M
Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
[TBL] [Abstract][Full Text] [Related]
28. [Antipsychotic drugs and their influence on the carbohydrate metabolism in patients with schizophrenia-spectrum disorders].
Tsygankov BD; Agasarain EG; Zykova AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(5):86-91. PubMed ID: 25035885
[TBL] [Abstract][Full Text] [Related]
29. [Hepatic tolerance of atypical antipsychotic drugs].
Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
[TBL] [Abstract][Full Text] [Related]
30. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
Leslie DL; Rosenheck RA
Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666
[TBL] [Abstract][Full Text] [Related]
31. Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care.
Nasrallah HA; Newcomer JW
J Clin Psychopharmacol; 2004 Oct; 24(5 Suppl 1):S7-14. PubMed ID: 15356415
[TBL] [Abstract][Full Text] [Related]
32. Atypical antipsychotics and diabetes mellitus: an association.
Liberty IF; Todder D; Umansky R; Harman-Boehm I
Isr Med Assoc J; 2004 May; 6(5):276-9. PubMed ID: 15151366
[TBL] [Abstract][Full Text] [Related]
33. The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists.
Newcomer JW; Nasrallah HA; Loebel AD
J Clin Psychopharmacol; 2004 Oct; 24(5 Suppl 1):S1-6. PubMed ID: 15356414
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data.
Rajagopalan K; Hassan M; O'Day K; Meyer K; Grossman F
J Med Econ; 2013 Jul; 16(7):951-61. PubMed ID: 23701260
[TBL] [Abstract][Full Text] [Related]
35. [Atypical antipsychotic induced weight gain and metabolic disorders].
Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C
Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331
[TBL] [Abstract][Full Text] [Related]
36. Atypical antipsychotic agents and increased risk of diabetes: class action or differential action?
Ananth J; Kolli S
Expert Opin Drug Saf; 2005 Jan; 4(1):55-68. PubMed ID: 15709898
[TBL] [Abstract][Full Text] [Related]
37. Metabolic risk during antipsychotic treatment.
Newcomer JW
Clin Ther; 2004 Dec; 26(12):1936-46. PubMed ID: 15823759
[TBL] [Abstract][Full Text] [Related]
38. Association between antipsychotic drugs and diabetes.
Holt RI; Peveler RC
Diabetes Obes Metab; 2006 Mar; 8(2):125-35. PubMed ID: 16448516
[TBL] [Abstract][Full Text] [Related]
39. Review of atypical antipsychotics and weight gain.
Sussman N
J Clin Psychiatry; 2001; 62 Suppl 23():5-12. PubMed ID: 11603886
[TBL] [Abstract][Full Text] [Related]
40. Drug therapy in schizophrenia.
Ananth J; Parameswaran S; Hara B
Curr Pharm Des; 2004; 10(18):2205-17. PubMed ID: 15281896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
